Security key
09090D301
BiomX Inc. - Common Stock, $0.0001 par value (PHGE)
CUSIP: 09090D301
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 1,527,040
- Total 13F shares
- 9,960,646
- Share change
- +561,587
- Total reported value
- $7,245,970
- Price per share
- $0.73
- Number of holders
- 16
- Value change
- +$283,360
- Number of buys
- 5
- Number of sells
- 6
Report period
Q4 2024
Institutions
16
Top holders
10
PHGE full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D301
Recent filing periods:
Top shareholders of PHGE - BiomX Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
117%
|
1,787,767
|
$1,823,522 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
117%
|
1,787,610
|
$1,823,362 | — | 30 Sep 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
113%
|
1,730,600
|
$1,765,212 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
58%
|
893,000
|
$910,860 | — | 30 Sep 2024 | |
| AIGH Capital Management LLC |
13F
|
Company |
57%
|
865,400
|
$882,708 | — | 30 Sep 2024 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
39%
|
589,027
|
$600,808 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
28%
|
432,700
|
$441,354 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
26%
|
401,136
|
$409,159 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
16%
|
237,400
|
$242,148 | — | 30 Sep 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
12%
|
192,321
|
$196,167 | — | 30 Sep 2024 | |
| 8VC GP I, LLC |
13F
|
Company |
6.8%
|
108,621
|
$110,793 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
1.6%
|
25,000
|
$25,500 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
3,785
|
$3,861 | — | 30 Sep 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
0.07%
|
1,101
|
$1,123 | — | 30 Sep 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.03%
|
400
|
$408 | — | 30 Sep 2024 | |
| OrbiMed Israel BioFund GP Limited Partnership |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
13,777,980
mixed-class rows
|
$5,250,517 | — | 15 May 2024 | |
| Chidozie Ugwumba |
3/4/5
|
Exit Form 4 - former 10% owner |
—
class O/S missing
|
2,997,025
|
$1,018,989 | — | 17 Oct 2022 | |
| Assaf Oron |
3/4/5
|
Chief Business Officer |
—
mixed-class rows
|
263,304
mixed-class rows
|
$9,836 | — | 16 Sep 2024 | |
| Paul J. Sekhri |
3/4/5
|
Director |
—
mixed-class rows
|
21,875
mixed-class rows
|
$4,250 | — | 28 Jul 2021 | |
| Dambach Michael E. |
3/4/5
|
Director |
—
class O/S missing
|
41,000
|
— | — | 21 Aug 2023 | |
| Lynne Marie Sullivan |
3/4/5
|
Director |
—
class O/S missing
|
41,000
|
— | — | 01 Mar 2023 | |
| Marks Jason M. |
3/4/5
|
Director |
—
class O/S missing
|
41,000
|
— | — | 21 Aug 2023 | |
| Gbolahan Amusa |
3/4/5
|
Director |
—
class O/S missing
|
20,500
|
— | — | 29 Mar 2022 | |
| Jonas Grossman |
3/4/5
|
Director |
—
class O/S missing
|
20,500
|
— | — | 29 Mar 2022 |
Institutional Holders of BiomX Inc. - Common Stock, $0.0001 par value (PHGE) as of Q4 2024
As of 31 Dec 2024,
BiomX Inc. - Common Stock, $0.0001 par value (PHGE) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,960,646 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Nantahala Capital Management, LLC, Ikarian Capital, LLC, AIGH Capital Management LLC, Alyeska Investment Group, L.P., Allostery Investments LP, JPMORGAN CHASE & CO, DAFNA Capital Management LLC, and HEIGHTS CAPITAL MANAGEMENT, INC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
13
Q4 2024 holders
16
Holder diff
3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.